These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 7557276

  • 1. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
    Castañeda Guillot C, Escobar Capote MD, García Bacallao E, Borbolla Bousquets E.
    G E N; 1994; 48(4):219-25. PubMed ID: 7557276
    [Abstract] [Full Text] [Related]

  • 2. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL, Weltman M, Dingley J, Fiatarone J, Hope AH, Craig PI, Grierson JM, Bilous M, Williams SJ, Farrell GC.
    Med J Aust; 1995 Jan 02; 162(1):8-11. PubMed ID: 7845310
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
    Cullu F, Tümay GT, Kutlu T, Erkan T, Ozbay G, Badur S.
    Gastroenterol Clin Biol; 1995 Jan 02; 19(1):53-7. PubMed ID: 7720991
    [Abstract] [Full Text] [Related]

  • 4. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Cadrobbi P, Nebbia G, Pillan MN, Lepore L, Parrella T.
    Hepatology; 1994 Aug 02; 20(2):287-90. PubMed ID: 8045488
    [Abstract] [Full Text] [Related]

  • 5. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S, Sokal E, Schaefer E, Pohlenz J, Keller KM.
    Monatsschr Kinderheilkd; 1992 Oct 02; 140(10):775-9. PubMed ID: 1435800
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
    Raptopoulou M, Orphanou H, Vrettou H, Akribiadis E, Chadzikonstantinou L, Goulis G.
    Gut; 1993 Oct 02; 34(2 Suppl):S102-3. PubMed ID: 8314469
    [Abstract] [Full Text] [Related]

  • 9. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV, Jara P, Hierro L, Diaz C, de la Vega A, Vegnente A, Iorio R, Bortolotti F, Crivellaro C, Zancan L, Daniels H, Portmann B, Mieli-Vergani G.
    Hepatology; 1996 Apr 02; 23(4):700-7. PubMed ID: 8666320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S, Bramou T, Makris A, Moussoulis G, Zignego L, Papaioannou C.
    J Hepatol; 1990 Apr 02; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [Abstract] [Full Text] [Related]

  • 12. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL, Lin HJ, Lau JN, Flok AS, Wu PC, Chung HT, Wong LK, Leung MP, Yeung CY.
    Q J Med; 1991 Feb 02; 78(286):155-63. PubMed ID: 2031078
    [Abstract] [Full Text] [Related]

  • 13. [Chronic infection due to hepatitis B virus in patients less than 16 years of age: therapeutic approach by means of interferon alfa-2b].
    Vetencourt R, Oropeza F, de Armas J, Cordero I, de Silva M, Machado I, Vetencourt M, Mendoza J.
    G E N; 1990 Feb 02; 44(4):353-60. PubMed ID: 2152277
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC, Brice E, van Rensburg C, Kannemeyer J, Hift RJ, Kirsch RE.
    S Afr Med J; 1992 Nov 02; 82(5):317-20. PubMed ID: 1448711
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 02; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
    Bayraktar Y, Uzunalimoglu B, Arslan S, Koseoglu T, Kayhan B, Telatar H.
    Gut; 1993 Jul 02; 34(2 Suppl):S101. PubMed ID: 8314468
    [Abstract] [Full Text] [Related]

  • 20. [Interferon alfa 2b treatment decreases histological activity in children with chronic hepatitis B].
    Castañeda C, García E, Grá B, Nodarse-Cuní H, García W, Andrade M, Martínez G, Trujillo M, Soto G, Amoroto M, Viada C, López-Saura P.
    Acta Gastroenterol Latinoam; 2002 May 02; 32(1):35-42. PubMed ID: 12136690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.